Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02499666 · ClinicalTrials.gov registry record
Change in Exercise Capacity as Measured by Peak Oxygen Uptake After CTO PCI
A clinical trial, sponsored by Henry Ford Health System.
- Terminated
- Registry status
- 15
- Enrollment target
NCT02499666 is a clinical trial that was terminated before completion, run by Henry Ford Health System. The registered enrollment target is 15 participants.
The verdict
NCT02499666 was terminated before completion, sponsored by Henry Ford Health System.
- TERMINATED
- Registry status
- 15 participants
- Enrollment target
Study Summary
The purpose of this project is to objectively assess the change (improvement) in exercise capacity in patients undergoing routine percutaneous coronary intervention (PCI) for chronic total occlusion (CTO)
Interventions
- DRUG Clopidogrel
- PROCEDURE Percutaneous Coronary Intervention
- DEVICE Coronary stent
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2015-06-29 |
| Est. Completion | 2017-10-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02499666
The ClinicalTrials.gov registry entry for NCT02499666 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Clopidogrel is the first listed.
NCT02499666 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02499666 about?
NCT02499666 is a clinical study titled "Change in Exercise Capacity as Measured by Peak Oxygen Uptake After CTO PCI". The purpose of this project is to objectively assess the change (improvement) in exercise capacity in patients undergoing routine percutaneous coronary intervention (PCI) for chronic total occlusion (CTO)
What is the current status of trial NCT02499666?
This trial is currently terminated. The enrollment target is 15 participants. The study started on 2015-06-29. Estimated completion is 2017-10-30.
What interventions are being tested in trial NCT02499666?
The interventions under investigation include: Clopidogrel (DRUG), Percutaneous Coronary Intervention (PROCEDURE), Coronary stent (DEVICE).
Who is sponsoring clinical trial NCT02499666?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.